Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
JNJ

JNJ - Johnson & Johnson Stock Price, Fair Value and News

$227.75+3.31 (+1.47%)
Market Closed

50/100

JNJ

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

50/100

JNJ

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$194.82

Target 3M

$213.54

Target 6M

$207.15

JNJ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

JNJ Price Action

Last 7 days

4.5%

Last 30 days

9.7%

Last 90 days

20.5%

Trailing 12 Months

51.5%

JNJ RSI Chart

JNJ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

JNJ Valuation

Market Cap

548.7B

Price/Earnings (Trailing)

21.84

Price/Sales (Trailing)

5.95

EV/EBITDA

14.65

Price/Free Cashflow

28

JNJ Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$194.82

Target 3M

$213.54

Target 6M

$207.15

JNJ Fundamentals

JNJ Revenue

Revenue (TTM)

92.1B

Rev. Growth (Yr)

6.77%

Rev. Growth (Qtr)

1.05%

JNJ Earnings

Earnings (TTM)

25.1B

Earnings Growth (Yr)

91.24%

Earnings Growth (Qtr)

-6.95%

JNJ Profitability

EBT Margin

34.19%

Return on Equity

31.69%

Return on Assets

13.03%

Free Cashflow Yield

3.57%

JNJ Investor Care

Dividend Yield

2.23%

Dividend/Share (TTM)

5.08

Shares Dilution (1Y)

0.07%

Diluted EPS (TTM)

10.36

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202589.3B90.6B92.1B0
202485.6B86.6B87.7B88.8B
202381.0B82.3B83.7B85.2B
202276.3B73.2B69.8B80.0B
202184.2B89.2B91.4B78.7B
202082.7B80.5B80.9B82.6B
201981.6B81.3B81.7B82.1B
201878.7B80.7B81.4B81.6B
201772.2B72.5B74.4B76.5B
201670.2B70.9B71.6B71.9B
201573.6B71.9B70.5B70.1B
201471.9B73.5B74.4B74.3B
201368.6B70.0B70.5B71.3B
201265.0B64.9B65.9B67.2B
201162.1B63.4B64.4B65.0B
201000061.6B
Get all data in R, Python etc through our Historical Stock Data APIs

About Johnson & Johnson

JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
 CEO
 WEBSITEjnj.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers General
 EMPLOYEES65535

Johnson & Johnson Frequently Asked Questions

JNJ is the stock ticker symbol of Johnson & Johnson. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Johnson & Johnson is 548.72 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check JNJ's fair value in chart for subscribers.

The fair value guage provides a quick view whether JNJ is over valued or under valued. Whether Johnson & Johnson is cheap or expensive depends on the assumptions which impact Johnson & Johnson's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for JNJ.

As of Wed Jan 28 2026, JNJ's PE ratio (Price to Earnings) is 21.84 and Price to Sales (PS) ratio is 5.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. JNJ PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Johnson & Johnson has provided 0.081 (multiply by 100 for percentage) rate of return.